SARS-CoV-2 antibodies in multiple sclerosis patients depending on the vaccine mode of action?

Rommer, Paulus S; Bsteh, Gabriel; Berger, Thomas; Zettl, Uwe Klaus

Rommer, Paulus S; Bsteh, Gabriel; Berger, Thomas; Zettl, Uwe Klaus.

Rommer PS; Department of Neurology, Medical University of Vienna, Vienna, Austria.
Bsteh G; Department of Neurology, Medical University of Vienna, Vienna, Austria.
Berger T; Department of Neurology, Medical University of Vienna, Vienna, Austria.
Zettl UK; Department of Neurology, Medical University of Vienna, Vienna, Austria.

Mult Scler ; 28(1): 165-167, 2022 01.

Article in English | MEDLINE | ID: covidwho-1597535

Subject(s)

COVID-19; Multiple Sclerosis; Vaccines; Antibodies, Viral; Humans; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / COVID-19 / Multiple Sclerosis Topics: Vaccines Limits: Humans Language: English Journal: Mult Scler Journal subject: Neurology Year: 2022 Document Type: Article Affiliation country: 13524585211039128

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google